Συγγραφείς:
Pezaro, C.J.
Omlin, A.
Mastris, K.
Attard, G.
Beer, T.M.
Chi, K.N.
Chowdhury, S.
Davis, I.D.
Drake, C.G.
de Bono, J.S.
Efstathiou, E.
Gravis, G.
Higano, C.S.
Hussain, M.
James, N.
Logothetis, C.J.
Morgans, A.
Parker, C.
Ryan, C.J.
Saad, F.
Sartor, O.
Small, E.J.
Sternberg, C.N.
Sweeney, C.J.
Tannock, I.
Tombal, B.
Gillessen, S.
ANZUP Consumer Advisory Panel
Λέξεις-κλειδιά:
abiraterone; abiraterone acetate; docetaxel; enzalutamide; testosterone, advanced cancer; androgen deprivation therapy; cancer survival; castration resistant prostate cancer; Editorial; human; measurement precision; medical terminology; metastatic prostate cancer; overall survival; practice guideline; priority journal; prostate cancer; stigma; castration resistant prostate cancer; classification; male; nomenclature, Humans; Male; Prostatic Neoplasms, Castration-Resistant; Terminology as Topic
